Early Approval For Flonase Generic Puts Glaxo In A Bind
A surprisingly early approval by U.S. regulators of a generic version of allergy treatment Flonase prompted GlaxoSmithKline Plc to rush to the courthouse this week, securing a restraining order that in...To view the full article, register now.
Already a subscriber? Click here to view full article